Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

DPP‐IV inhibition enhances the antilipolytic action of NPY in human adipose tissue
Katarina Kos, Andrew H. Baker, Margareta Jernås, et al.
Diabetes Obesity and Metabolism (2009) Vol. 11, Iss. 4, pp. 285-292
Closed Access | Times Cited: 80

Showing 1-25 of 80 citing articles:

Lipolysis and lipid mobilization in human adipose tissue
Max Lafontan, Dominique Langin
Progress in Lipid Research (2009) Vol. 48, Iss. 5, pp. 275-297
Closed Access | Times Cited: 747
Dipeptidyl Peptidase 4 Is a Novel Adipokine Potentially Linking Obesity to the Metabolic Syndrome
Daniela Lamers, Susanne Famulla, Nina Wronkowitz, et al.
Diabetes (2011) Vol. 60, Iss. 7, pp. 1917-1925
Open Access | Times Cited: 559
Cardiovascular Biology of the Incretin System
John R. Ussher, Daniel J. Drucker
Endocrine Reviews (2012) Vol. 33, Iss. 2, pp. 187-215
Open Access | Times Cited: 510
DPP4 in diabetes
Diana Röhrborn
Frontiers in Immunology (2015) Vol. 6
Open Access | Times Cited: 387
Incretin-Based Therapies for Type 2 Diabetes Mellitus: Properties, Functions, and Clinical Implications
Michael A. Nauck
The American Journal of Medicine (2010) Vol. 124, Iss. 1, pp. S3-S18
Closed Access | Times Cited: 285
An emerging role of dipeptidyl peptidase 4 (DPP4) beyond glucose control: Potential implications in cardiovascular disease
Jixin Zhong, Xiaoquan Rao, Sanjay Rajagopalan
Atherosclerosis (2012) Vol. 226, Iss. 2, pp. 305-314
Closed Access | Times Cited: 204
Adipose Dipeptidyl Peptidase-4 and Obesity
Henrike Sell, Matthias Blüher, Nora Klöting, et al.
Diabetes Care (2013) Vol. 36, Iss. 12, pp. 4083-4090
Open Access | Times Cited: 200
In vitro inhibition of dipeptidyl peptidase IV by peptides derived from the hydrolysis of amaranth (Amaranthus hypochondriacus L.) proteins
Aída Jimena Velarde‐Salcedo, Alberto Barrera-Pacheco, Samuel Lara‐González, et al.
Food Chemistry (2012) Vol. 136, Iss. 2, pp. 758-764
Closed Access | Times Cited: 198
Dipeptidyl peptidase IV inhibitor sitagliptin reduces local inflammation in adipose tissue and in pancreatic islets of obese mice
Anca D. Dobrian, Qi Ma, John W. Lindsay, et al.
AJP Endocrinology and Metabolism (2010) Vol. 300, Iss. 2, pp. E410-E421
Open Access | Times Cited: 156
Role of Dipeptidyl Peptidase 4 Inhibitors in Antidiabetic Treatment
Ruili Yin, Yongsong Xu, Xin Wang, et al.
Molecules (2022) Vol. 27, Iss. 10, pp. 3055-3055
Open Access | Times Cited: 49
Fatty acid flux in adipocytes: The in's and out's of fat cell lipid trafficking
Brian R. Thompson, Sandra Lobo, David Bernlohr
Molecular and Cellular Endocrinology (2009) Vol. 318, Iss. 1-2, pp. 24-33
Open Access | Times Cited: 113
Adipose tissue lipolysis
C. Kolditz, Dominique Langin
Current Opinion in Clinical Nutrition & Metabolic Care (2010) Vol. 13, Iss. 4, pp. 377-381
Closed Access | Times Cited: 111
Neuropeptide Y Is Produced by Adipose Tissue Macrophages and Regulates Obesity-Induced Inflammation
Kanakadurga Singer, David L. Morris, Kelsie E. Oatmen, et al.
PLoS ONE (2013) Vol. 8, Iss. 3, pp. e57929-e57929
Open Access | Times Cited: 98
Cafeteria diet-induced obesity plus chronic stress alter serum leptin levels
Isabel Cristina de Macedo, Liciane Fernandes Medeiros, Cleverson Moraes de Oliveira, et al.
Peptides (2012) Vol. 38, Iss. 1, pp. 189-196
Open Access | Times Cited: 86
Antidiabetic treatment with gliptins: focus on cardiovascular effects and outcomes
Enrique Z. Fisman, Alexander Tenenbaum
Cardiovascular Diabetology (2015) Vol. 14, Iss. 1
Open Access | Times Cited: 81
Acute and chronic saturated fatty acid treatment as a key instigator of the TLR-mediated inflammatory response in human adipose tissue, in vitro
Elham M Youssef-Elabd, Kirsty McGee, Gyanendra Tripathi, et al.
The Journal of Nutritional Biochemistry (2011) Vol. 23, Iss. 1, pp. 39-50
Open Access | Times Cited: 70
Plasma dipeptidyl peptidase 4 activity correlates with body mass index and the plasma adiponectin concentration in healthy young people
Yasushi Kirino, Masako Sei, Kazuyoshi Kawazoe, et al.
Endocrine Journal (2012) Vol. 59, Iss. 10, pp. 949-953
Open Access | Times Cited: 66
The Role of “Mixed” Orexigenic and Anorexigenic Signals and Autoantibodies Reacting with Appetite-Regulating Neuropeptides and Peptides of the Adipose Tissue-Gut-Brain Axis: Relevance to Food Intake and Nutritional Status in Patients with Anorexia Nervosa and Bulimia Nervosa
Kvido Smitka, Hana Papežová, K Vondra, et al.
International Journal of Endocrinology (2013) Vol. 2013, pp. 1-21
Open Access | Times Cited: 57
Characterization of Dedifferentiating Human Mature Adipocytes from the Visceral and Subcutaneous Fat Compartments: Fibroblast-Activation Protein Alpha and Dipeptidyl Peptidase 4 as Major Components of Matrix Remodeling
Julie Lessard, Mélissa Pelletier, Laurent Biertho, et al.
PLoS ONE (2015) Vol. 10, Iss. 3, pp. e0122065-e0122065
Open Access | Times Cited: 53
Dipeptidyl Peptidase 4 (DPP4) as A Novel Adipokine: Role in Metabolism and Fat Homeostasis
Ilaria Barchetta, Flavia Agata Cimini, Sara Dule, et al.
Biomedicines (2022) Vol. 10, Iss. 9, pp. 2306-2306
Open Access | Times Cited: 27
DPP‐IV Inhibitory Peptides From Whey Proteins: Production, Functional Mechanisms, Bibliometric Insights, and Future Directions for Type 2 Diabetes Therapy
Laura García‐Curiel, Olvera‐Rosales Laura Berenice, Cruz‐Guerrero Alma Elizabeth, et al.
Peptide Science (2025) Vol. 117, Iss. 2
Closed Access
DPP-4 inhibitors in diabetic complications: role of DPP-4 beyond glucose control
Eun Ju Bae
Archives of Pharmacal Research (2016) Vol. 39, Iss. 8, pp. 1114-1128
Closed Access | Times Cited: 46
Dipeptidyl-peptidase 4 Inhibition: Linking Metabolic Control to Cardiovascular Protection
Angelo Avogaro, Saula Vigili de Kreutzenberg, Gian Paolo Fadini
Current Pharmaceutical Design (2014) Vol. 20, Iss. 14, pp. 2387-2394
Open Access | Times Cited: 44
Activity and selectivity cliffs for DPP‐IV inhibitors: Lessons we can learn from SAR studies and their application to virtual screening
María José Ojeda, Aleix Gimeno, Sarah Tomas‐Hernández, et al.
Medicinal Research Reviews (2018) Vol. 38, Iss. 6, pp. 1874-1915
Closed Access | Times Cited: 41
DPP4 Gene DNA Methylation in the Omentum is Associated With Its Gene Expression and Plasma Lipid Profile in Severe Obesity
Valérie Turcot, Luigi Bouchard, Geneviève Faucher, et al.
Obesity (2010) Vol. 19, Iss. 2, pp. 388-395
Open Access | Times Cited: 53
Page 1 - Next Page

Scroll to top